In recent years, non-penetrating glaucoma surgery has been seen as a safer alternative to trabeculectomy. This class of procedures is mainly represented by 'deep sclerectomy', 'viscocanalostomy,' and 'canaloplasty' (a recent and more reproducible variation of viscocanalostomy). The aim of all these procedures is to allow drainage of the aqueous humor from the anterior chamber, not through a patent scleral opening but by slow percolation through the inner trabecular meshwork and/or Descemet's membrane ('sclerodescemetic membrane'). This avoids sudden drops in intraocular pressure (IOP), hypotony, and flat chambers. The absence of anterior chamber opening and iridectomy limits the risk of cataract and infection. The advantages of viscocanalostomy and canaloplasty are that not only are they non-penetrating, like deep sclerectomy, but also, most importantly, they restore the physiologic outflow pathway, thus avoiding external filtration in the majority of eyes. This makes the success of the procedure partly independent of conjunctival or episcleral scarring, a leading cause of failure in trabeculectomy, with fewer indications for wound healing modulation. Moreover, the absence of an elevated filtering bleb avoids related ocular discomfort, and the procedures can be carried out in any quadrant.
Operative Technique
Viscocanalostomy is a demanding surgical technique that requires a long learning curve. 1 First, a fornix-based conjunctival flap is created. Then, a 5 x 5 mm outer parabolic flap, approximately 200 μm thick, is dissected, followed by an inner concentrically 4 x 4 mm scleral flap sculpted beneath the previous one (see Figure 1 ). The internal flap should be dissected deep enough to have a dark reflex from the underlying choroid. While the cut is advanced anteriorly, Schlemm's canal is de-roofed. The two ostia of Schlemm's canal are then cannulated with the specific 190 μm cannula and Schlemm's canal is dilated by slow and repeated injections of high-molecular-weight sodium hyaluronate (see Figure 2 ). During canaloplasty, dilation of Schlemm's canal is made by catheterization of the entire canal length with a microcatheter and by controlled release of high-molecular-weight sodium hyaluronate inside the whole canal. A 10-0 polypropylene suture is then passed inside the canal and, through a suture loop, tightened to distend the trabecular meshwork inward placing the tissue in tension (see Figure 3 ).
By gently pulling the inner scleral flap upwards and delicately depressing the floor of the canal and Descemet's membrane with the tip of a cotton swab, the membrane itself is then cleaved from the cornea and the cleavage is advanced in clear cornea for approximately 1 mm, thus creating the so-called 'trabeculo-descemetic window' (see Figure 4) .
As soon as the window is completed, the inner scleral flap is excised.
The next step is the sealing of the lake, which is obtained by tightly suturing the outer scleral flap with seven 10-0 nylon stitches.
High-molecular-weight sodium hyaluronate is then injected underneath the flap to fill the intrascleral space temporarily, preventing it from collapsing and scarring in the early post-operative period. Finally, the conjunctiva is sutured in place.
Mechanism of Action
Viscocanalostomy increases the aqueous outflow through different paths. Injection of viscoelastic into the canal not only dilates the canal and associated collectors but also disrupts the internal and external walls of Schlemm's canal and adjacent trabecular layers, thus increasing the trabecular outflow facility and making the procedure act as a 'micro-trabeculotomy' (see Figure 5 ). 2 Aqueous outflow facility is also increased by damage to the inner wall of Schlemm's canal and adjacent trabeculum at the site of surgery, thus enhancing aqueous outflow into the scleral lake. From here, aqueous can leave the eye via three different paths:
• through the cut ends and previously nonfunctional sectors of Schlemm's canal to collector channels;
• by external filtration into the subconjunctival space; or
• by absorption into the subchoroidal space.
External filtration and filtering blebs are uncommon in viscocanalostomy and can only be detected by biomicroscopy or by ultrasound biomicroscopy in up to one-third of eyes. 3 A supraciliary hypoechoic area, suggesting aqueous drainage into the subchoroidal space, has been shown by the use of ultrasound biomicroscopy (see Figure 6 ). 4 In eyes with elevated IOP after surgery, a small opening of the trabeculo-descemetic membrane can be made using a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser. This procedure, named 'laser goniopuncture,' enhances the external filtration, thereby changing the basic mechanism of action of viscocanalostomy, and is indicated in eyes where Schlemm's canal dilation was insufficient to increase the trabecular outflow facility significantly. The rate of laser goniopuncture varies among viscocanalostomy studies from 4 5 to 33 %. 6 In a larger study on canaloplasty (a procedure with well-controlled Schlemm's canal dilation), the need for goniopuncture was only 4.7 %. In a four-year follow-up prospective study, Gilmour et al. 15 confirmed better results after trabeculectomy than after viscocanalostomy and a significantly higher success rate: an IOP <18 mmHg with no medication was achieved in 42 % of the eyes after trabeculectomy and in 21 % after viscocanalostomy (p=0.018).
To date, only one randomized controlled trial 16 has been performed with the aim of comparing non-penetrating glaucoma surgery (in 19 eyes), including viscocanalostomy (11 eyes), with trabeculectomy (11 eyes) for refractive changes. Post-operative IOP levels and visual acuity (logMar values) did not differ among groups. Average induced astigmatism was lower in the non-penetrating surgery group than in the trabeculectomy group and showed a less against-the-rule shift over six months.
A retrospective study 17 has compared phaco-viscocanalostomy with phaco-trabeculectomy. At three years, phaco-viscocanalostomy showed a higher success rate (IOP <21 mmHg with no medication) than phaco-trabeculectomy, 58.2 versus 36.0 %, and a lower incidence of vision-threatening complications. A more recent prospective randomized comparison 18 showed no significant differences between the two procedures with regard to IOP control and success rate; however, there were fewer complications associated with phaco-viscocanalostomy.
To try to achieve more conclusive results, three articles have reported the meta-analysis of studies that compared viscocanalostomy with trabeculectomy. The first two papers by Cheng et al. 19, 20 showed that trabeculectomy had a better efficacy with a risk difference for complete success of -0.16 (95 % confidence interval [CI]: -0.30 to -0.02), a mean IOP reduction at two years of 45.6 % for trabeculectomy and 30.2 % for viscocanalostomy, and a complete success rate at four years of 47.6 and 22.7 %, respectively. The two studies confirmed fewer complications after viscocanalostomy than after trabeculectomy. Chai et al. 21 confirmed these results: they showed that trabeculectomy had a greater pressure-lowering effect but a higher complication rate.
Only one retrospective study has compared canaloplasty with trabeculectomy with 12 months of follow-up. 22 Canaloplasty was highly effective in reducing IOP with a final IOP of 13.3 ± 3.6 mmHg and a mean percentage decrease of pressure from baseline of 32 ± 22 %. Given that the major changes are made at the trabecular meshwork level, the procedure cannot be effective when the angle is closed or neovascularized, or when Schlemm's canal is likely to be damaged. This is the case in previously operated eyes where an extensive cautery of the perilimbal area has been made. However, eyes with hypertension or glaucoma owing to trabecular meshwork impairment should respond the best to viscocanalostomy. This has been shown, for example, in glaucomas secondary to uveitis (with well-controlled inflammation), 23 in juvenile glaucomas 24 and in congenital glaucomas. 
Summary and Key Points
Viscocanalostomy is an effective surgery for lowering IOP in 
